Close Menu

NEW YORK (360Dx) – Even as the deaths of former National Football League players have put the spotlight on concussions, diagnosing the injury remains a tricky business, sometimes relying on art as well as science.

Boston-based BioDirection hopes to change that with a blood-based test that it said can offer an objective diagnosis within 90 seconds. If all goes according to plan, the test could hit the market in Europe in about a year, followed by a launch in the US.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.